New Delhi, February 7

Anti-dumping duty has been imposed on as many as 90 items imported from China that include two pharmaceutical products, Parliament was informed on Friday.

“Further, 24 anti-dumping investigations are presently in progress against the alleged dumping of imports from China,” Commerce and Industry Minister Piyush Goyal said in a written reply to the Rajya Sabha.

The Directorate General of Trade Remedies (DGTR), under the commerce ministry, conducts anti-dumping investigations on the basis of a duly substantiated application filed by the domestic industry alleging dumping of goods into the country causing injury to the domestic industry.

The minister said that the basic intent of anti-dumping measures is to eliminate injury caused to the domestic industry by the unfair trade practice of dumping and to create a level-playing field for the domestic industry.

In a separate reply, he said the government has been consistently making efforts for achieving a more balanced trade with China.

India’s trade with China decreased from $89.71 billion in 2017-18 to $87.07 billion in 2018-19.

During this period, India’s imports from China declined from $76.38 billion in 2017-18 to $70.32 billion in 2018-19, and “our exports grew from $13.33 billion in 2017-18 to $16.75 billion in 2018-19,” he said.

“As a result, India’s trade deficit with China reduced from $63.05 billion to $53.57 billion in the said period,” he added.

He , however, said that there are reports of some goods of Chinese origin coming into India from other countries like Singapore and Hong Kong, on which field formations have been appropriately sensitised.